This article summarized the latest R&D progress of lusutrombopag, the Mechanism of Action for lusutrombopag, and the drug target R&D trends for lusutrombopag.
In the wake of the receding tide of COVID-19 oral medication and vaccines, Pfizer seems to have returned to an awkward predicament where all potential growth points have fallen flat.
This article summarized the latest R&D progress of methscopolamine bromide, the Mechanism of Action for methscopolamine bromide, and the drug target R&D trends for methscopolamine bromide.
This article summarized the latest R&D progress of methsuximide, the Mechanism of Action for methsuximide, and the drug target R&D trends for methsuximide.
Despite Novartis being a consistent top contender in the pharmaceutical sector in terms of revenue, its growth and market value in recent years has been rather dismal.
Androgen receptor (AR) is a type of nuclear receptor that is activated by binding of either of the androgenic hormones testosterone or dihydrotestosterone in the cytoplasm and then translocating into the nucleus.
In conjunction with Zealand Pharma A/S, Boehringer Ingelheim has initiated three Phase III research investigations for survodutide (also known as BI 456906)